Dexamethasone mouth wash

Drug Profile

Dexamethasone mouth wash

Alternative Names: Dexamethasone mouth rinse; Dexamethasone mouthwash; Dexamethasone-based mouth wash

Latest Information Update: 07 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novartis
  • Class Anti-inflammatories; Antiemetics; Antineoplastics; Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Stomatitis

Most Recent Events

  • 06 Sep 2017 Phase II development is ongoing in USA, Argentina and Brazil (NCT02069093) (NCT01698918)
  • 01 Mar 2016 Novartis Pharmaceuticals completes the STOPP trial in Stomatitis (Prevention) in USA (Buccal) (NCT02069093)
  • 01 May 2014 Phase-II clinical trials in Stomatitis (Prevention) in USA (Buccal) (NCT02069093)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top